×
0.622137404580153 0.612595419847328 0.57442748091603 0.564885496183206 0.583969465648855 1.29961832061069 1.13740458015267 1.1469465648855
Stockreport

Gemcabene Meets Primary Endpoint in INDIGO-1 Study of Severe Hypertriglyceridemia (SHTG) Patients

Gemphire Therapeutics, Inc (GEMP)  More Company Research Source: GlobeNewswire
Last gemphire therapeutics, inc earnings: 11/8 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.gemphire.com
PDF Gemcabene demonstrated statistically significant lowering of triglycerides (TGs) in SHTG Secondary endpoints achieved included statistically significant reductions in serum LDL-C, non-HDL-C, VLDL-C, apoB, apoE, apoCIII, and SAA Gemcabene showed evidence of safety and tolerability in combination with statins INDIGO-1 results further support Gemphire’s rationale for developing gemcabene as a treatment for NAFLD/NASH Conference call and webcast today, Thursday, June 28, at 4:30 p.m. Eastern Time LIVONIA, Mich., June 28, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ:GEMP), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders, including dyslipidemia and nonalcoholic steatohepatitis (NASH), today announced that it achieved the primary endpoint, reduction of TGs by gemcabene, in its Phase 2b INDIGO-1 trial in SHTG patients with baseline serum TGs 500 mg/dL. Key findings: Primary endpoint met with m [Read more]

IMPACT SNAPSHOT EVENT TIME: GEMP
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS
Opt-in for
GEMP alerts
from News Quantified
Opt-in for
GEMP alerts

from News Quantified
Opt-in for
GEMP alerts

from News Quantified